Peroxisome proliferator-activated receptor δ promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage
Chih‐Hao Lee, Kihwa Kang, Isaac R. Mehl et al. · Proceedings of the National Academy of Sciences · 2006
Significant attention has focused on the role of low-density lipoprotein (LDL) in the pathogenesis of atherosclerosis. However, recent advances have identified triglyceride-rich lipoproteins [e.g., very LDL (VLDL)] as independent risk predictors for this disease. We have previously demonstrated peroxisome proliferator-activated receptor (PPAR)delta, but not PPARgamma, is the major nuclear VLDL sensor in the macrophage, which is a crucial component of the atherosclerotic lesion. Here, we show that, in addition to beta-oxidation and energy dissipation, activation of PPARdelta by VLDL particles induces key genes involved in carnitine biosynthesis and lipid mobilization mediated by a recently identified TG lipase, transport secretion protein 2 (also named desnutrin, iPLA2zeta, and adipose triglyceride lipase), resulting in increased fatty acid catabolism. Unexpectedly, deletion of PPARdelta results in derepression of target gene expression, a phenotype similar to that of ligand activation, suggesting that unliganded PPARdelta suppresses fatty acid utilization through active repression, which is reversed upon ligand binding. This unique transcriptional mechanism assures a tight control of the homeostasis of VLDL-derived fatty acid and provides a therapeutic target for other lipid-related disorders, including dyslipidemia and diabetes, in addition to coronary artery disease.
Cited by 98 works. doi:10.1073/pnas.0510815103
Authors
- Chih‐Hao Lee
- Kihwa Kang
- Isaac R. Mehl
- Russell R. Nofsinger
- William A. Alaynick
- Ling-Wa Chong
- John M. Rosenfeld
- Ronald M. Evans
References
- THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
- Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
- PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
- PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
- Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
- PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
- Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
- Nuclear Receptors and Lipid Physiology: Opening the X-Files